In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 3 - ST Elevation Acute Coronary Sydrome: Prognosis and Biomarkers
Session

Event : Acute Cardiovascular Care 2018

Topic : Other

  • Session type : Poster Session
  • Date : 04 March 2018
  • Time : 09:00 - 12:30

18 presentations in this session

Female sex is an independent predictor of short term mortality in STEMI patients treated by primary PCI

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : S Cornara (Pavia,IT)

Can the shock index predict in-hospital mortality of patients with STEMI?

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : J Lujan Valencia (Sevilla,ES)

Express algorithm of the estimation of the risk of bleeding in patients with STEMI

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : V Leonova (Kemerovo,RU)

Do females really have a higher mortality rate after Primary PCI in STEMI?

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : A Duka (Tirana,AL)

Acute STEMI in the very elderly patients. Results of the prospective ALKK-Registry.

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : O Mohammad (Mannheim,DE)

Impact of gender on prognosis in STEMI patients of a regional primary angioplasty network

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : C Labata Salvador (Barcelona,ES)

STEMI prognosis in elderly patients: do reperfusion networks benefit them?

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : MT Oliveras Vila (Badalona,ES)

In-hospital complications and mortality in ST-elevation myocardial infarction (STEMI) patients declined from 2008 to 2014

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : A Sinkovic (Maribor,SI)

Early predictors of in-hospital mortality in high-risk ST-elevation myocardial infarction (STEMI) patients

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : A Sinkovic (Maribor,SI)

Prognostic implications of influenza virus infection in a cardiac intensive care unit. Impact of a screening program.

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : L Vicent Alaminos (Madrid,ES)

Magnitude and prognostic utility of ventricular dysfunction in post-cardiac arrest syndrome

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : R Ramos Polo (Girona,ES)

Long-term outcome of patients with very long stents for treatment of diffuse coronary disease in current practice.

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : P Perez Diaz (Ciudad Real,ES)

The possibility of hemorrhagic risk prediction in the preoperative period of open myocardial revascularization

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : K Krivoshapova (Kemerovo,RU)

Prognostic markers of myocardial remodeling in patients with ST segment elevation myocardial infarction

Event : Acute Cardiovascular Care 2018

  • Session : Prognosis and Biomarkers
  • Speaker : Y Shaposhnikova (Kharkiv,UA)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are